<DOC>
	<DOCNO>NCT00578552</DOCNO>
	<brief_summary>Gabapentin anti-epileptic agent show preliminary evidence efficacy improve symptom cocaine alcohol withdrawal pilot study . Since neurobiology alcohol , cocaine nicotine withdrawal similar , preliminary evidence efficacy gabapentin symptom alcohol cocaine withdrawal suggest , gabapentin might likely help nicotine withdrawal symptom thus tobacco abstinence . The effect gabapentin two neurotransmitter , gamma-aminobutyric acid ( GABA ) glutamate suggest potential therapeutic mechanism gabapentin tobacco abstinence . However , exact mechanism action gabapentin currently know . We recently complete open label pilot trial gabapentin tobacco abstinence involve 50 smoker . The finding study provide promise preliminary result suggest test gabapentin help cigarette smoker quit tobacco use worth pursuing . Overall , gabapentin well tolerate low abuse potential . Our goal evaluate novel , safe , acceptable , effective therapy may help increase tobacco abstinence rate . Currently , randomize trial test efficacy gabapentin smoke abstinence publish . While previous study provide promising evidence regard potential efficacy gabapentin smoking abstinence , additional dose range study need prior pursue large randomize trial . The primary aim dose range study obtain additional evidence efficacy , information optimal dose gabapentin employ large randomize control trial .</brief_summary>
	<brief_title>Gabapentin Smoking Cessation</brief_title>
	<detailed_description>A total 120 participant recruit study randomly assign one three group . Participants group A receive gabapentin 1800-mg/day orally 12-weeks participant group B receive gabapentin 2700-mg/day orally 12-weeks . Participants group C receive match placebo duration . We select dose regimen base experience use gabapentin pilot study . The present study design randomize , blind , placebo-controlled , three-arm , parallel-group , dose-ranging , phase II clinical trial . In addition receive gabapentin placebo , subject receive brief behavioral counseling intervention participation study .</detailed_description>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>1 . Are 18 65 year age 2 . Have smoke ≥10 cigarettes/day past 1 year 3 . Are willing make quit attempt 4 . Are able participate fully aspects study ; 5 . Have provide , understand , sign informed consent . 1 . Meet diagnostic criterion current major depressive disorder lifetime history bipolar disorder schizophrenia . Patients mild moderate depressive symptom assess CESD determine physician , meet current diagnostic criterion major depressive disorder , include 2 . Are currently ( within past 30 day ) use antipsychotic , antidepressant 3 . Are currently ( previous 30 day ) use tobacco treatment program ( i.e. , behavioral therapy , nicotine replacement therapy , bupropion SR , clonidine , nortriptyline ) 4 . Have use investigational drug within 30 day prior enrol study 5 . Have recent history ( past year ) alcohol abuse dependence assess CAGE questionnaire study investigator 6 . Have recent history drug abuse assess Drug Abuse Screening Test 20 ( DAST20 ) physician interview 7 . Are pregnant , lactating , child bear potential , likely become pregnant medication phase willing use contraception . The following birth control measure acceptable : birth control pill , approve intrauterine contraceptive device , use two combine barrier method ( diaphragm spermicide condom spermicide ) , injection , surgical sterilization abstinence 8 . Have history major cardiovascular event past 6 month include unstable angina , acute MI coronary angioplasty 9 . Have clinically significant acute chronic progressive unstable neurologic ( myasthenia gravis ) , hepatic , renal , cardiovascular , respiratory ( bronchospastic disease ) metabolic disease 10 . Are currently follow prescribe medication know interact gabapentin unable stop study : Maalox® , cimetidine morphine . Patients caution use sedative ( benzodiazepine , antihistamine , anticholinergic , trazodone , zaleplon , antipsychotic , barbiturate , opiate , zolpidem eszopiclone ) study 11 . Have another household member relative participating study 12 . Have know allergy gabapentin constituent ; 13 . Are professional driver operator heavy machinery unable refrain activity medication phase study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>tobacco</keyword>
	<keyword>smoking</keyword>
	<keyword>gabapentin</keyword>
	<keyword>abstinence</keyword>
</DOC>